These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 35297258)

  • 1. Hepatic amyloidosis: a prevalence study and clinical characterization of a rare and severe disease.
    Dias E; Cardoso H; Marques M; Liberal R; Lopes S; Pereira P; Santos-Antunes J; Pinheiro J; Lopes J; Carneiro F; Macedo G
    Rev Esp Enferm Dig; 2023 Jan; 115(1):16-21. PubMed ID: 35297258
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Two cases of systemic amyloidosis presenting with abnormalities in liver function tests].
    Park JH; Park CK; Yun YM; Hyun DW; Kim ES; Park SY; Jo CM; Tak WY; Kweon YO; Kim SK; Choi YW
    Korean J Gastroenterol; 2003 Oct; 42(4):341-6. PubMed ID: 14634355
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute liver failure due to primary amyloidosis in a nephrotic syndrome: a swiftly progressive course.
    Cardoso BA; Leal R; Sá H; Campos M
    BMJ Case Rep; 2016 Mar; 2016():. PubMed ID: 26965175
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Giant hepatomegaly and portal hypertension in an elderly patient with primary liver amyloidosis: an uncommon clinical occurrence.
    Basile G; Villari D; Nicita-Mauro V
    Eur Rev Med Pharmacol Sci; 2000; 4(1-2):47-50. PubMed ID: 11409189
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary systemic amyloidosis with giant hepatomegaly and a swiftly progressive course.
    Mainenti PP; Petrelli G; Lamanda R; Amalfi G; Castiglione F
    J Clin Gastroenterol; 1997 Apr; 24(3):173-5. PubMed ID: 9179738
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Marked hepatomegaly due to AA type amyloidosis in a case with Castleman's disease.
    Yamagata N; Fujio J; Hirai R; Matsumaru M; Tanimura S; Inokuchi C; Shikai T; Takezako N; Nasu M; Sakata Y; Sata N; Nagai H; Saito K; Miwa A
    Int J Hematol; 2006 Jul; 84(1):70-3. PubMed ID: 16867906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Case of Severe Cholestasis due to Hepatic AL Amyloidosis.
    Dias T; Ferreira D; Moreira H; Nascimento T; Santos A; Carvalho A
    GE Port J Gastroenterol; 2019 Oct; 26(6):425-429. PubMed ID: 31832498
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hepatic amyloidosis as cause of severe intrahepatic cholestasis].
    Gavilán JC; Bermúdez FJ; Márquez A; Sánchez-Carrillo JJ; González-Santos P
    An Med Interna; 2003 Jan; 20(1):25-7. PubMed ID: 12666305
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary systemic amyloidosis with giant hepatomegaly and portal hypertension: a case report and a review of the literature.
    Serra L; Poppi MC; Criscuolo M; Zandomeneghi R
    Ital J Gastroenterol; 1993 Oct; 25(8):435-8. PubMed ID: 8286779
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatic amyloidosis (primary [AL], immunoglobulin light chain): the natural history in 80 patients.
    Gertz MA; Kyle RA
    Am J Med; 1988 Jul; 85(1):73-80. PubMed ID: 3389383
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kidney and liver involvement in monoclonal light chain disorders.
    Pozzi C; Locatelli F
    Semin Nephrol; 2002 Jul; 22(4):319-30. PubMed ID: 12118397
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Diagnostic difficulties in hepatic amyloidosis--clinical analysis and autopsy data of 3 cases].
    Dabrowska E; Jabłońska-Kaszewska I; Sworczak K; Sliwińska I
    Pol Arch Med Wewn; 1990 Sep; 84(3):176-81. PubMed ID: 2267176
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatic amyloidosis with light chain deposition disease. A rare association.
    Casiraghi MA; De Paoli A; Assi A; Palladini G; Lavazza MT; Beretta A; Gualdoni G; Beretta R
    Dig Liver Dis; 2000 Dec; 32(9):795-8. PubMed ID: 11215561
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatic Involvement as the Sole Presentation of Systemic Amyloid Light Chain (AL) Amyloidosis: A Diagnostic Challenge.
    Kottavadakkeel N; Rajaram A
    Cureus; 2023 Oct; 15(10):e47310. PubMed ID: 38022076
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatomegaly and cholestasis as primary clinical manifestations of an AL-kappa amyloidosis.
    Mohr A; Miehlke S; Klauck S; Röcken C; Malfertheiner P
    Eur J Gastroenterol Hepatol; 1999 Aug; 11(8):921-5. PubMed ID: 10514129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rare case of acute on chronic hepatic failure in a patient with multiple myeloma-associated amyloidosis.
    Muhammad Khan M; Ur Rashid M; Ullah W; Hussain I; Hurairah A
    BMJ Case Rep; 2020 Jan; 13(1):. PubMed ID: 31996385
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Massive Hepatomegaly Secondary to Amyloidosis with Normal Liver Chemistries.
    Doe-Williams S; Hixson LJ; Pfeiffer DC
    Case Rep Gastroenterol; 2020; 14(2):271-278. PubMed ID: 32518538
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatic Amyloidosis as a Rare Cause of Liver Failure: A Case Report.
    Ghazanfar H; Khaja M; Haider A; Yapor L; Kandhi S; Sulh M
    Cureus; 2022 Jul; 14(7):e27274. PubMed ID: 36039232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Analysis of clinical manifestations and prognosis of primary systemic light chain amyloidosis with liver involvement].
    Qiao TT; Liu Y; Peng N; Gong LZ; Dou XL; Wen L; Lu J
    Zhonghua Gan Zang Bing Za Zhi; 2024 Mar; 32(3):222-227. PubMed ID: 38584103
    [No Abstract]   [Full Text] [Related]  

  • 20. Primary (AL) hepatic amyloidosis: clinical features and natural history in 98 patients.
    Park MA; Mueller PS; Kyle RA; Larson DR; Plevak MF; Gertz MA
    Medicine (Baltimore); 2003 Sep; 82(5):291-8. PubMed ID: 14530778
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.